English
Specials
Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
you are here:

Quant Healthcare Fund - Direct Plan - IDCW

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : Quant Mutual Fund
  • NAV
    : ₹ 16.1948 -0.06%
    (as on 12th September, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Fund Size
: ₹ 384.01 Cr
(0.08% of Investment in Category)
 Expense Ratio
: 0.8%
(0.88% Category average)
Risk-O-Meter
Very High Risk

The fund has 86.5% investment in domestic equities of which 17.82% is in Large Cap stocks, 6.44% is in Mid Cap stocks, 37.55% in Small Cap stocks.The fund has 4.4% investment in Debt, of which 4.4% in Government securities.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    NIFTY Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
₹
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 12th September, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 05-Sep-25 10264.60 2.65% - 1.41% 12/226
1 Month 12-Aug-25 10497.90 4.98% - 3.32% 41/224
3 Month 12-Jun-25 10053.00 0.53% - 2.85% 150/216
6 Month 12-Mar-25 11654.40 16.54% - 16.94% 102/211
YTD 01-Jan-25 9891.60 -1.08% - 3.47% 140/201
1 Year 12-Sep-24 9027.20 -9.73% -9.73% -0.64% 160/178
2 Year 12-Sep-23 15035.70 50.36% 22.59% 20.08% 43/139
Since Inception 17-Jun-23 16194.80 61.95% 24.00% 14.08% 19/199
Returns Calculator Detailed Returns Analysis

SIP Returns (NAV as on 12th September, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 12-Sep-24 12000 12374.39 3.12 % 5.82 %
2 Year 12-Sep-23 24000 27394.11 14.14 % 13.25 %
SIP Calculator Detailed Returns Analysis
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Equity Holding : 86.50% | F&O Holdings : 12.07%| Foreign Equity Holdings : 0.00%| Total : 98.57%
No of Stocks : 19 (Category Avg - 44.16) | Large Cap Investments : 17.82%| Mid Cap Investments : 6.44% | Small Cap Investments : 37.55% | Other : 36.78%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Aster DM Healthcare Ltd. Hospital 386 10.05% 0.04% 10.05% (Aug 2025) 6.45% (Sep 2024) 6.42 L -0.35 L
RPG Life Sciences Ltd Pharmaceuticals 349.3 9.10% 0.26% 9.28% (Mar 2025) 7.72% (Nov 2024) 1.51 L 0.00
Anthem Biosciences Ltd. Biotechnology 261.8 6.82% 0.88% 6.82% (Aug 2025) 0% (Sep 2024) 3.20 L 0.00
Zydus Wellness Ltd. Packaged foods 259.1 6.75% 0.38% 6.75% (Aug 2025) 5.69% (Sep 2024) 1.28 L 0.00
Lupin Ltd. : Futures Near Pharmaceuticals 250.5 6.52% 0.31% 6.52% (Aug 2025) 0% (Sep 2024) 1.31 L 0.85 L
Sequent Scientific Ltd. Pharmaceuticals 250.2 6.51% 0.31% 6.79% (May 2025) 4.76% (Mar 2025) 14.77 L 0.00
Pfizer Ltd. Pharmaceuticals 247.3 6.44% 0.35% 7.23% (Sep 2024) 5.22% (Mar 2025) 47.95 k 0.00
Glenmark Life Sciences Ltd. Pharmaceuticals 232.7 6.06% -0.15% 7.34% (Jan 2025) 5.71% (Dec 2024) 2.46 L 0.00
HDFC Life Insurance Company Ltd. Life insurance 229.6 5.98% 0.49% 5.98% (Aug 2025) 0% (Sep 2024) 2.97 L 0.00
Aurobindo Pharma Ltd. Pharmaceuticals 223.4 5.82% -0.24% 6.99% (Sep 2024) 5.8% (Jun 2025) 2.17 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Detailed Portfolio Analysis
No of Debt Holding 7 (Category Avg - 1.04) | Modified Duration 0.00 Years (Category Avg - 0.00)| Yield to Maturity - -- (Category Avg - 0.00%)

Type of Holdings

Security Type
% Weight
Category Average
GOI 0.00% 0.01%
T-Bills 4.40% 0.47%

Investment / Portfolio Grades

Security Type
% Weight
Category Average
Government Backed 4.40% 0.48%
Low Risk 0.00% 0.00%
Moderate Risk 0.00% 0.00%
High Risk 0.00% 0.00%
Very High Risk 0.00% 0.00%
Others 0.00% 0.00%
Detailed Portfolio Analysis
Name Type of Instrument Weight (%)
TREPS TREPS 10.29%
Net Receivables Net Receivables -13.27%
Detailed Portfolio Analysis

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)

    No data available. Ratios are only available for the funds which are 3 years old.

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth NA 389.09 12.63 30.65 52.12 52.14 33.04
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth NA 249.75 3.43 11.53 19.61 28.71 17.27
Nippon India Japan Equity Fund - Direct Plan - Growth NA 283.56 3.22 10.49 15.86 19.19 18.55
Motilal Oswal Business Cycle Fund - Direct Plan - Growth NA 1976.19 7.24 7.39 17.72 19.09 0.00
Franklin Asian Equity Fund - Direct - Growth NA 259.99 4.52 9.16 16.22 17.55 11.52
Nippon India US Equity Opportunities Fund - Direct Plan - Growth NA 713.51 2.98 5.84 10.54 17.51 18.35
DSP Banking & Financial Services Fund - Direct Plan - Growth NA 1331.23 2.48 -0.26 15.87 15.58 0.00
SBI Banking & Financial Services Fund - Direct Plan - Growth NA 8370.76 1.11 1.39 17.96 12.72 18.73
Baroda BNP Paribas Banking and Financial Services Fund - Direct Plan - Growth NA 295.43 0.96 -0.47 15.12 11.70 16.58
WhiteOak Capital Banking & Financial Services Fund - Direct Plan - Growth NA 468.18 0.75 1.17 17.78 10.93 0.00

More Funds from Quant Mutual Fund

Out of 29 mutual fund schemes offered by this AMC, 2 is/are ranked 3 * , 3 is/are ranked 2 * , 5 is/are ranked 1 * , and 19 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Quant Small Cap Fund - Direct Plan - Growth 3 28758.03 2.64 0.24 15.71 -8.84 24.39
Quant ELSS Tax Saver Fund - Direct Plan - Growth 1 11396.21 2.73 0.73 14.82 -9.73 14.73
Quant Multi Cap Fund - Direct Plan - Growth 1 9200.34 2.87 -1.49 11.25 -12.86 12.45
Quant Mid Cap Fund - Direct Plan - Growth 1 8318.96 0.72 -3.91 8.73 -13.27 17.09
Quant Flexi Cap Fund - Direct Plan - Growth 2 6686.67 3.06 -0.96 11.02 -11.30 16.75
Quant Multi Asset Allocation Fund - Direct Plan - Growth NA 3666.29 2.15 3.11 14.28 3.84 20.33
Quant Large and Mid Cap Fund - Direct Plan - Growth 1 3488.01 1.55 -2.90 10.09 -11.77 16.96
Quant Infrastructure Fund - Direct Plan - Growth NA 3139.54 1.89 -0.31 11.84 -10.47 17.97
Quant Large Cap Fund - Direct Plan - Growth NA 2657.55 1.99 0.78 14.86 -6.66 14.68
Quant Aggressive Hybrid Fund - Direct Plan - Growth 1 2057.69 1.86 1.17 13.45 -3.30 12.25
All funds

Forum

POST

+ See More

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347